Julia R. Van Liew
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Julia R. Van Liew has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Alan J. Christensen
Department of Psychology, The University of Iowa, Iowa City, Iowa
2 shared publicationsGerry F. Funk
Department of Otolaryngology, Grande Ronde Hospitals and Clinics, La Grande, Oregon
1 shared publicationJanet S. de Moor
National Cancer Institute/NIH
1 shared publicationLucy Hynds Karnell
Department of Otolaryngology - Head and Neck Surgery, The University of Iowa College of Medicine, Iowa City, Iowa
1 shared publication- Nitin A. Pagedar
Department of Otolaryngology‐Head and Neck Surgery University of Iowa Iowa City Iowa USA
1 shared publication - Rebecca L. Brock
Department of Psychology The University of Nebraska‐Lincoln Lincoln Nebraska USA
1 shared publication
Latest Publications
- 5 October 2016
- Published by Wiley in Head & Neck
- Vol. 39 (2) , 370-379
Weight loss after head and neck cancer: A dynamic relationship with depressive symptoms
Background: Weight loss and depressive symptoms are critical head and neck cancer outcomes, yet their relation over the illness course is unclear.Methods: Associations between self‐reported depressive symptoms and objective weight loss across the year after head and neck cancer diagnosis were examined using growth curve modeling techniques (n = 564).Results: A reciprocal covariation pattern emerged–changes in depressive symptoms over time were associated with same‐month changes in weight loss (t [1148] = 2.05; p = .041), and changes in weight loss were associated with same‐month changes in depressive symptoms (t [556] = 2.43; p = .015). To the extent that depressive symptoms increased, patients lost incrementally more weight than was lost due to the passage of time and vice versa. Results also suggested that pain and eating‐related quality of life might explain the reciprocal association between depressive symptoms and weight loss.Conclusion: In head and neck cancer, a transactional interplay between depressive symptoms and weight loss unfolds over time. © 2016 Wiley Periodicals, Inc. Head Neck 39: 370–379, 2017
- 5 October 2016
- Published by Wiley in Head & Neck
- Vol. 39 (2) , 370-379
Weight loss after head and neck cancer: A dynamic relationship with depressive symptoms
Background: Weight loss and depressive symptoms are critical head and neck cancer outcomes, yet their relation over the illness course is unclear.Methods: Associations between self‐reported depressive symptoms and objective weight loss across the year after head and neck cancer diagnosis were examined using growth curve modeling techniques (n = 564).Results: A reciprocal covariation pattern emerged–changes in depressive symptoms over time were associated with same‐month changes in weight loss (t [1148] = 2.05; p = .041), and changes in weight loss were associated with same‐month changes in depressive symptoms (t [556] = 2.43; p = .015). To the extent that depressive symptoms increased, patients lost incrementally more weight than was lost due to the passage of time and vice versa. Results also suggested that pain and eating‐related quality of life might explain the reciprocal association between depressive symptoms and weight loss.Conclusion: In head and neck cancer, a transactional interplay between depressive symptoms and weight loss unfolds over time. © 2016 Wiley Periodicals, Inc. Head Neck 39: 370–379, 2017
- 2 July 2014
- Published by Springer Nature in Journal of Cancer Survivorship
- Vol. 8 (3) , 521-531
Psychosocial factors in adjuvant hormone therapy for breast cancer: an emerging context for adherence research
For patients with hormone receptor positive breast cancer, survivorship entails prolonged self-management of adjuvant treatment in the form of daily hormone therapy. Although sustained daily adherence across the 5-year course of therapy is associated with improved recurrence-free survival outcomes, adherence is suboptimal and many women discontinue hormone therapy prematurely. Factors associated with breast cancer survivors’ nonadherence and nonpersistence are not comprehensively understood. Furthermore, psychosocial variables have only received limited research attention, despite their documented relationships with adherence in other chronic illness populations. A systematic literature review identified 14 studies that analyzed relationships between psychosocial factors and breast cancer survivors’ adherence and/or persistence with adjuvant hormone therapy. Although identified relationships were complex and at times inconsistent, salient conclusions emerged. Interpersonal factors, in the form of positive social support and patient-centered interactions with medical providers, as well as intrapersonal factors, such as anxiety and beliefs about the relative benefits of medication use, were reliably associated with better adherence and persistence. Depression did not demonstrate the negative impact on adherence that has been observed in other medical populations. No relationships between quality of life and adherence were identified. Adjuvant hormone therapy appears to be a unique context for medication adherence, which warrants further attention and more rigorous analysis in future research. Individual patients’ psychosocial characteristics and health care preferences should be considered when striving to optimize medication adherence.
- 2 July 2014
- Published by Springer Nature in Journal of Cancer Survivorship
- Vol. 8 (3) , 521-531
Psychosocial factors in adjuvant hormone therapy for breast cancer: an emerging context for adherence research
For patients with hormone receptor positive breast cancer, survivorship entails prolonged self-management of adjuvant treatment in the form of daily hormone therapy. Although sustained daily adherence across the 5-year course of therapy is associated with improved recurrence-free survival outcomes, adherence is suboptimal and many women discontinue hormone therapy prematurely. Factors associated with breast cancer survivors’ nonadherence and nonpersistence are not comprehensively understood. Furthermore, psychosocial variables have only received limited research attention, despite their documented relationships with adherence in other chronic illness populations. A systematic literature review identified 14 studies that analyzed relationships between psychosocial factors and breast cancer survivors’ adherence and/or persistence with adjuvant hormone therapy. Although identified relationships were complex and at times inconsistent, salient conclusions emerged. Interpersonal factors, in the form of positive social support and patient-centered interactions with medical providers, as well as intrapersonal factors, such as anxiety and beliefs about the relative benefits of medication use, were reliably associated with better adherence and persistence. Depression did not demonstrate the negative impact on adherence that has been observed in other medical populations. No relationships between quality of life and adherence were identified. Adjuvant hormone therapy appears to be a unique context for medication adherence, which warrants further attention and more rigorous analysis in future research. Individual patients’ psychosocial characteristics and health care preferences should be considered when striving to optimize medication adherence.
- 1 January 2013
- Published by Springer Nature
- p. 1171
Locus of Control
- 30 October 2012
- Published by Springer Nature in Journal of Clinical Psychology in Medical Settings
- Vol. 19 (4) , 411-417
Balancing Confidentiality and Collaboration Within Multidisciplinary Health Care Teams
As multidisciplinary perspectives are increasingly integrated into the treatment of health problems, opportunities for clinical psychologists in medical settings are expanding. Although cross-discipline collaboration is at the core of multidisciplinary treatment models, psychologists must be particularly cautious about information sharing due to their profession’s ethical standards regarding patient confidentiality. Psychologists’ ethical obligations require them to achieve a delicate balance between contributing to the treatment team and protecting patient confidentiality. In the current review, relevant ethical standards and federal guidelines are applied to everyday practices of clinical psychologists in medical settings. Additionally, recommendations for individual psychologists, health care organizations, and graduate training programs are presented.
- 30 October 2012
- Published by Springer Nature in Journal of Clinical Psychology in Medical Settings
- Vol. 19 (4) , 411-417
Balancing Confidentiality and Collaboration Within Multidisciplinary Health Care Teams
As multidisciplinary perspectives are increasingly integrated into the treatment of health problems, opportunities for clinical psychologists in medical settings are expanding. Although cross-discipline collaboration is at the core of multidisciplinary treatment models, psychologists must be particularly cautious about information sharing due to their profession’s ethical standards regarding patient confidentiality. Psychologists’ ethical obligations require them to achieve a delicate balance between contributing to the treatment team and protecting patient confidentiality. In the current review, relevant ethical standards and federal guidelines are applied to everyday practices of clinical psychologists in medical settings. Additionally, recommendations for individual psychologists, health care organizations, and graduate training programs are presented.